DOD
Search
Discussions
Biomedical Jobmarket
News
DOD Alert
Edit DOD
 
ACCOUNT
Login
Register
Forgotten Password?
 
 
Oral
 
Diabetes OD > Disease Management > T2DM > Metabolic Control > Anti-Hyperglycemic and Anti-Apoptotic Agents > Incretin Hormones > GLP-1 > Effectivity of GLP-1 in Therapy > Effectivity of Administration Forms > Oral

Oral


(Journal Article): Glucagon-like peptide-l (7-37) suppresses hyperglyeaemia in rats.
 
Hendrick GK, Gjinovci A, Baxter LA, Mojsov S, Wollheim CB, Habener JF, Weir GC
 
IN: Metabolism 1993; 42(1):1-6
Impact Factor(s) of Metabolism: 2.143 (2004), 2.013 (2003), 1.931 (2001)

ABSTRACT: Glucagon-like peptide-(GLP) I-(7-37) is an endogenous hormone that has recently been demonstrated to be a potent insulin secretagogue. In these studies, GLP was administered during... Click HERE for details

 



 
Contribute to this subject area!